secwatch.observer — SEC 8-K summary
======================================

Issuer:     Streamex Corp. (STEX)
CIK:        0001530766
Form:       8-K
Filed at:   2022-03-22T23:59:59+00:00
Accession:  0001185185-22-000308
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioSig appoints John Sieckhaus as COO; brings 30 years healthcare experience
----------------------------------------------------------------------------

- John Sieckhaus appointed COO effective March 21, 2022; base salary $280,000, annual bonus eligible.
- Received signing bonus of 50,000 fully vested shares plus options for 350,000 shares vesting over 3 years.
- 30 years healthcare; previously VP Field Clinical Affairs at Abbott and Sr. VP/GM at St. Jude Medical.
- Company plans national rollout of PURE EP system; 75 physicians performed 2150+ patient cases.
- Clinical study showed 93% consensus and 75% improvement in intracardiac signal quality with PURE EP.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1530766/000118518522000308/0001185185-22-000308-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1530766/000118518522000308/biosig20220318_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-22-000308

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer